Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatropin Dose Comparison in Turner Syndrome
NCT01734486Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 1996
- Primary completion
- May 2003
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of somatropin in Turner syndrome (TS) (2 arms), sponsored by Novo Nordisk. Primary endpoints: Height gain, Standard Deviation Score at 3 years and Height gain in cm at 3 years. Started Sep 1996; status: completed.
02
Drugs
somatropin
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on NCT01734486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01734486.